Author

Liang Zhu

Shanghai Jiao Tong UniversityORCID 0000-0002-9383-392XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Liang Zhu3 papers · Shanghai Jiao Tong University

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Ayinazhaer Aihemaiti· 1 shared Baohui HaniD· 1 shared Chan XiangiD· 1 shared Hongyu Liu· 1 shared Hongzhuan CHENiD· 1 shared Hua ZhongiD· 1 shared Hui-min LeiiD· 1 shared Jun LuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ayinazhaer Aihemaiti

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyNature CommunicationsPeer-reviewedMay 7, 2026

A non-canonical glucose metabolic rewiring enables resistance to cancer targeted therapy

Hui-min Lei, Ruixue Xia, Yabin Tang…·Liang Zhu

The paper identifies a non-canonical glucose metabolic pathway involving GLUT6 that contributes to resistance to cancer targeted therapies in lung cancer.

DOI 10.1038/s41467-026-72922-7

humanmetabolomics

𝕏 PostBluesky